Summary
Profile
Financials
Events
Ownership
Options

Company Info

Industry Semiconductors
Sector Electronic Technology
Employees 15,900
CEO Mr. Vincent T. Roche
Address One Analog Way , Wilmington, MA 01887-9106
Phone 1.781.329.4700
Website www.analog.com

Analog Devices, Inc. engages in the design, development, manufacture, and marketing of integrated circuits (ICs). Its products include industrial process control systems, medical imaging equipment, factory process automation systems, patient vital signs monitoring devices, instrumentation and measurement systems, wireless infrastructure equipment, energy management systems, networking equipment, aerospace and defense electronics, optical systems, automobiles, and portable consumer devices. The company was founded by Raymond P. Stata and Matthew Lorber in 1965 and is headquartered in Wilmington, MA.

Competitors

Company Name 3 Month
%Change
1 Year
%Change
Analog Devices, Inc. 6.22% 51.57%
Intel Corp. -4.24% 7.11%
Broadcom, Inc. 7.78% 38.44%
Texas Instruments Incorporated 4.75% 41.31%
QUALCOMM, Inc. -1.53% 16.86%

Statement Summary

as of 4:00 ET PM 09/21/2021
Total Assets (MRQ) 21.6 B
Total Liabilities (MRQ) 9.4 B
Shareholders’ Equity (MRQ) 12.3 B
Total Revenue (Annual) 1.8 B
Net Income (Annual) 503.3 M

Earnings And Estimates

as of 4:00 ET PM 09/21/2021

Current Qtr EPS Estimate 1.71
Current FY EPS Estimate 6.40
Long Term EPS Growth Estimate 11.42
Next Expected Earnings Date 11/30/2021

ADI vs S&P 500

as of 09/21/2021
Relative To
S&P 500
ADI
4 Weeks n/a n/a
12 Weeks n/a n/a
YTD n/a n/a

Earnings Surprises

as of 4:00 ET PM 09/21/2021
Fiscal Quarter Estimate Actual Surprise
07/2021 1.62 1.72 +6.50%
04/2021 1.45 1.54 +6.05%
01/2021 1.33 1.44 +8.64%
10/2020 1.33 1.44 +8.41%
07/2020 1.30 1.35 +3.99%
04/2020 1.03 1.08 +4.85%
01/2020 1.00 1.03 +3.10%
10/2019 1.22 1.19 -2.33%

Financial Strength

as of 4:00 ET PM 09/21/2021
Pre-Tax Margin 32.54
Net Margin 14.90
Operating Margin 35.16
Return On Equity 14.15
Return On Assets 7.87
Inventory Turnover (TTM) 3.95
Sales Growth (MRQ) 10.28

Ratios

as of 4:00 PM ET 09/21/2021
Price/Earnings (TTM) 37.34
Price/Book (MRQ) 5.22
Price/Cash Flow (TTM) 26.20
Book Value (MRQ) 33.31
Quick Ratio (MRQ) 0.87
Current Ratio (MRQ) 1.11
Total Debt/Equity (MRQ) 0.42

Short Interest

as of 4:00 PM ET 09/22/2021
% Short - 0.00%
% Remaining Float - 100.00%
Current Last Month
Short Interest Date n/a n/a
Short Interest Shares 0 0
Short Interest Ratio 0.0 0.0
M Y M Y
Total Assets 0,0.00 0,0.00
Total Liabilities 0,0.00 0,0.00
Total Equity 0,0.00 0,0.00
M Y M Y
Total Revenue 0,0.00 0,0.00
EBT Exc.
Unusual Items
0,0.00 0,0.00
Net Income 0,0.00 0,0.00
M Y M Y
Cash from
Operations
0,0.00 0,0.00
Cash from
Activities
0,0.00 0,0.00
Cash from
Fin. Activities
0,0.00 0,0.00

TOTAL ASSETS

TOTAL LIABILITIES

TOTAL EQUITY

Balance Sheet

M Y
ASSETS
Cash And Equivalents 0,0.00
Receivables 0,0.00
Inventories 0,0.00
Other Current Assets 0,0.00
Total Current Assets 0,0.00
Property, Plant & Equipment, Gross 0,0.00
Accumulated Depreciation & Depletion 0,0.00
Property, Plant & Equipment, Net 0,0.00
Intangibles 0,0.00
Other Non-Current Assets 0,0.00
Total Non-Current Assets 0,0.00
TOTAL ASSETS 0,0.00
Liabilities & Shareholder Equity
Accounts Payable 0,0.00
Short Term Debt 0,0.00
Total Current Liabilities 0,0.00
Long Term Debt 0,0.00
Deferred Income Taxes 0,0.00
Other Non-Current Liabilities 0,0.00
Minority Interest 0,0.00
Total Non-Current Liabilities 0,0.00
Preferred Stock Equity 0,0.00
Common Stock Equity 0,0.00
Common Par 0,0.00
Additional Paid In Capital 0,0.00
Cumulative Translation Adjustment 0,0.00
Retained Earnings 0,0.00
Treasury Stock 0,0.00
Other Equity Adjustments 0,0.00
Total Capitalization 0,0.00
TOTAL EQUITY 0,0.00
TOTAL LIABILITIES & STOCK EQUITY 0,0.00
Total Common Shares Outstanding 0,0.00
Preferred Shares 0,0.00
Treasury Shares 0,0.00
Basic Weighted Shares Outstanding 0,0.00
Diluted Weighted Shares Outstanding 0,0.00
Number Of Employees 0,0.00
Number Of Part-Time Employees 0,0.00

TOTAL REVENUES

EBT Excluding Unusual Items

NET INCOME

Income Statement

M Y
Sales 0,0.00
Cost Of Sales 0,0.00
Gross Operating Profit 0,0.00
Selling, General, And Administrative Expenses 0,0.00
Research & Development 0,0.00
Operating Income Before D & A (EBITDA) 0,0.00
Depreciation & Amortization 0,0.00
Interest Income 0,0.00
Other Income - Net 0,0.00
Special Income / Charges 0,0.00
Total Income Before Interest Expenses (EBIT) 0,0.00
Interest Expense 0,0.00
Pre-Tax Income 0,0.00
Income Taxes 0,0.00
Minority Interest 0,0.00
Net Income From Continuing Operations 0,0.00
Net Income From Discontinued Operations 0,0.00
Net Income From Total Operations 0,0.00
Extraordinary Income/Losses 0,0.00
Income From Cum. Effect Of Acct. Change 0,0.00
Income From Tax Loss Carryforward 0,0.00
Other Gains / Losses 0,0.00
Total Net Income 0,0.00
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Preferred Dividends 0,0.00
Net Income Available To Common 0,0.00
Basic EPS From Continuing Ops. 0,0.00
Basic EPS From Discontinued Ops. 0,0.00
Basic EPS From Total Operations 0,0.00
Basic EPS From Extraordinary Inc. 0,0.00
Basic EPS From Cum Effect Of Accounting Change 0,0.00
Basic EPS From Tax Loss Carryf'd. 0,0.00
Basic EPS From Other Gains (Losses) 0,0.00
Basic EPS, Total 0,0.00
Basic Normalized Net Income/Share 0,0.00
EPS From Continuing Ops. 0,0.00
EPS From Discontinued Ops 0,0.00
EPS From Total Ops. 0,0.00
EPS From Extraord. Inc. 0,0.00
EPS From Cum Effect of Accounting Change 0,0.00
EPS From Tax Loss Carfd. 0,0.00
EPS From Other Gains (L) 0,0.00
EPS, Total 0,0.00
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Dividends Paid Per Share 0,0.00

CASH FROM OPERATIONS

CASH FROM INVESTING ACTIVITIES

CASH FROM FINANCING ACTIVITIES

Cash Flow Statement

M Y
Cash Flow From Operating Activities
Net Income (Loss) 0,0.00
Operating Gains/Losses 0,0.00
Gross Operating Profit 0,0.00
(Increase) Decrease In Receivables 0,0.00
(Increase) Decrease In Inventories 0,0.00
(Increase) Decrease In Other Current Assets 0,0.00
(Decrease) Increase In Other Current Liabilities 0,0.00
(Increase) Decrease In Other Working Capital 0,0.00
Other Non-Cash Items 0,0.00
Net Cash From Continuing Operations 0,0.00
Net Cash From Discontinued Operations 0,0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 0,0.00
Sale Of Property, Plant & Equipment 0,0.00
Cash Used For Investing Activities
Sale Of Short-Term Investments 0,0.00
Purchases Of Property, Plant & Equipment 0,0.00
Acquisitions 0,0.00
Purchases Of Short-Term Investments 0,0.00
Other Cash From Investing Activities 0,0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities 0,0.00
Issuance Of Debt 0,0.00
Cash Used For Financing Activities
Issuance Of Capital Stock 0,0.00
Repayment Of Long-Term Debt 0,0.00
Repurchase Of Capital Stock 0,0.00
Payment Of Cash Dividends 0,0.00
Other Financing Charges, Net 0,0.00
Net Cash From Financing Activities 0,0.00
Effect Of Exchange Rate Changes 0,0.00
Net Change In Cash & Cash Equivalents 0,0.00

Earnings Estimates

as of 4:00 ET PM 09/21/2021
Current Qtr
(10/2021)
Next Qtr
(01/2022)
Consensus Estimate $1.71 $1.71
# of Estimates 23 21
High Estimate $1.79 $1.87
Low Estimate $1.69 $1.60
Year Ago EPS $1.05 $1.05
Year Over Year Growth Estimate 63.36% 62.24%
Current Yr
(10/2021)
Next Yr
(10/2022)
Consensus Estimate $6.40 $7.31
# of Estimates 25 26
High Estimate $6.47 $8.00
Low Estimate $6.06 $6.95
Year Ago EPS $4.91 $6.40
Year Over Year Growth Estimate 30.42% 14.18%
Current Qtr
(10/2021)
Next Qtr
(01/2022)
Current Year
(10/2021)
Next Year
(10/2022)
Consensus Estimate $1.71 $1.71 $6.40 $7.31
# of Estimates 23 21 25 26
High Estimate $1.79 $1.87 $6.47 $8.00
Low Estimate $1.69 $1.60 $6.06 $6.95
Year Ago EPS $1.05 $1.05 $4.91 $6.40
Year Over Year Growth Estimate 63.36% 62.24% 30.42% 14.18%

Insider Information Summary

as of 08/31/2021
% Insiders - 0.42%
% Remaining Total Shares - 99.58%
Current 1 Month
Net Insider Transaction 805.70 K -27.60 K
Shares Bought 869.38 K 42.83 K
Shares Sold 63.68 K 70.43 K

Insider Activity

Transaction Date Insider/Title Transaction Type Market Value Shares Average Price Current Holdings

LATEST NEWS

Recent Articles from TheStreet

Pfizer vaccine Lead

Pfizer Stock Higher As FDA Clears COVID Booster Shots For Older And At-Risk Americans

The FDA said older and at-risk Americans can receive a third 'booster' shot of Pfizer's COVID vaccine six months after their second.

boeing (2)

Boeing Stock Gains After China Demand Forecast Boosted To $1.5 Trillion

Boeing said Thursday that China will need around $1.5 trillion worth of new aircraft over the next 20 years, while spending a further $1.8 trillion on services.

Wall Street Lead

Stocks Gain As Fed Waits On Tapering, Pfizer Gets FDA Boosters Nod - 5 Things You Must Know

Stock futures gain as Fed punts on taper; Powell says strong September jobs report could start ball rolling; Tech, auto bosses meet with White House on chip shortage; Boeing boosts China demand forecast and Pfizer gets FDA approval for COVID boosters.

Stock Trader Lead

Eargo Slammed on Criminal Probe, Withdrawn Guidance

Shares lose half their value in after-hours trading Wednesday after disclosure of investigation into insurance reimbursement claims.

NYSE Trader Lead

Gee, That Stock Looks Great on You

When stocks go on sale, don't run for the exits. Try poking around the bargain bin for something you've been looking for.

wall-street-bull (4)

Cramer's Mad Money Recap: Jay Powell and Xi Jinping

Jim Cramer says stocks rallied because China's President Xi and Fed Chair Jay Powell made decisions that they knew would lead to rallies.